{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:32:46Z","timestamp":1790652766811,"version":"4.1.0"},"reference-count":22,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1150,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[1998,11]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The incidence of skin rashes or erythema multiforme to sulfamethoxazole in exposed patients is about 3%. Among patients with acquired immunodeficiency syndrome the risk is \u2248\u200310 times higher. The pathogenesis of these reactions and the reason for the increased frequency in HIV infections are not understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate drug specific T\u2010cell\u2010mediated cytotoxicity in sulfamethoxazole\u2010 induced skin reactions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Specific T\u2010cell lines and T\u2010cell clones generated from a donor who developed a skin rash to sulfamethoxazole were assessed with a standard 4\u2003h <jats:sup>51<\/jats:sup>Cr cytotoxicity assay in the presence or absence of soluble sulfamethoxazole. B lymphoblasts and keratinocytes with and without interferon gamma pretreatment were used as target cells. Selective blockers of FasL\/Fas and perforin\u2010mediated killing and immunostaining for perforin were used to evaluate the involvement of the different cytolytic pathways.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> sulfamethoxazole specific T\u2010cell clones showed a drug\u2010specific and MHC\u2010restricted cytotoxicity against autologous B lymphoblasts in the presence of soluble sulfamethoxazole. Keratinocytes, if pretreated with interferon gamma, were specifically killed predominantly by CD4<jats:sup>+<\/jats:sup> T\u2010cell clones. Specific T\u2010cell clones of both CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> phenotype showed a strong immunoreactivity for perforin and the cytotoxicity was blocked by concanamycin A which suggests a perforin\u2010mediated killing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Perforin\u2010mediated killing of autologous keratinocytes in the presence of soluble sulfamethoxazole by drug\u2010specific CD4<jats:sup>+<\/jats:sup> lymphocytes may be a pathway for generalized drug\u2010induced delayed skin reactions. The requirement of interferon gamma pretreatment of keratinocytes for efficient specific killing might explain the increased frequency of drug allergies in generalized viral infections like HIV, when interferon gamma levels are elevated.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2222.1998.00419.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T09:30:37Z","timestamp":1047375037000},"page":"1412-1417","source":"Crossref","is-referenced-by-count":125,"title":["T\u2010cell\u2010mediated cytotoxicity against keratinocytes in sulfamethoxazol\u2010induced skin reaction"],"prefix":"10.1111","volume":"28","author":[{"family":"Schnyder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Frutig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Mauri\u2010Hellweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Limat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yawalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/4.2.426"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1997.tb01038.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306103282304"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1996.tb94146.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00917741"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1994.tb06078.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.1.180"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90706-4"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119505"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.1.462"},{"key":"e_1_2_6_12_2","first-page":"181","article-title":"Quantitative assay of the lytic action of immune lymphoid cells on 51Cr\u2010labelled allogeneic target cells in vitro; Inhibition by isoantibody and by drugs","volume":"14","author":"Brunner KT","year":"1968","journal-title":"Immunology"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.4049\/jimmunol.156.10.3678","article-title":"Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin\u2010 and Fas\u2010 based lytic pathways in cell\u2010mediated cytotoxicity","volume":"156","author":"Kataoka T","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12722530"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1182\/blood.V85.8.2182.bloodjournal8582182","article-title":"Interleukin 12 expression in human lymphomas and nonneoplastic lymphoid disorders","volume":"85","author":"Schwaller J","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_16_2","first-page":"569","article-title":"Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine\u2010induced activation status","volume":"81","author":"Ritter M","year":"1994","journal-title":"Immunology"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.207"},{"key":"e_1_2_6_18_2","first-page":"389","article-title":"Successful prophylaxis of pneumocystis carinii pneumonia with trimethoprim\u2010sulfamethoxazole in AIDS patients with previous allergic reactions","volume":"2","author":"Shafer RW","year":"1989","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)80090-0"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.1.7"},{"key":"e_1_2_6_21_2","first-page":"158","article-title":"Interferon\u2010\u03b3 concentrations are increased in sera from individuals infected with human immunodefiency virus Type I","volume":"2","author":"Fuchs D","year":"1989","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1995.19"},{"key":"e_1_2_6_23_2","first-page":"851","article-title":"T cell subsets in toxic epidermal necrolysis","volume":"127","author":"Miyauchi H","year":"1991","journal-title":"Arch Dermatol"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.1998.00419.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.1998.00419.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2222.1998.00419.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T13:19:58Z","timestamp":1697375998000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2222.1998.00419.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["10.1046\/j.1365-2222.1998.00419.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2222.1998.00419.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}